1. Home
  2. UDMY vs ZVRA Comparison

UDMY vs ZVRA Comparison

Compare UDMY & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Udemy Inc.

UDMY

Udemy Inc.

HOLD

Current Price

$4.63

Market Cap

716.5M

Sector

Real Estate

ML Signal

HOLD

Logo Zevra Therapeutics Inc.

ZVRA

Zevra Therapeutics Inc.

HOLD

Current Price

$10.26

Market Cap

653.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UDMY
ZVRA
Founded
2009
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
716.5M
653.2M
IPO Year
2021
2015

Fundamental Metrics

Financial Performance
Metric
UDMY
ZVRA
Price
$4.63
$10.26
Analyst Decision
Buy
Strong Buy
Analyst Count
8
5
Target Price
$9.29
$23.00
AVG Volume (30 Days)
1.5M
1.3M
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
105.36
159.21
EPS
N/A
0.60
Revenue
$789,844,000.00
$106,470,000.00
Revenue This Year
$4.12
$37.27
Revenue Next Year
$4.54
$53.42
P/E Ratio
N/A
$17.05
Revenue Growth
0.42
350.91
52 Week Low
$4.02
$7.16
52 Week High
$8.09
$13.16

Technical Indicators

Market Signals
Indicator
UDMY
ZVRA
Relative Strength Index (RSI) 47.24 48.99
Support Level $4.23 $8.30
Resistance Level $5.20 $11.07
Average True Range (ATR) 0.30 0.62
MACD -0.01 -0.10
Stochastic Oscillator 46.77 18.05

Price Performance

Historical Comparison
UDMY
ZVRA

About UDMY Udemy Inc.

Udemy Inc operates a marketplace platform at the center of a vibrant knowledge network. The company operates under two operating and reportable segments Enterprise segment and Consumer segment, out of which the Enterprise segment derives the maximum revenue. Geographically, the company derives maximum revenue from North America, and also has its presence in Europe, Middle East, Africa; Asia Pacific; and Latin America. The company leverages data, technology, and insights for effective learning experiences. It helps individuals and organizations to possess effective skill acquisition and development with flexibility.

About ZVRA Zevra Therapeutics Inc.

Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward key milestones, and delivering meaningful outcomes for patients with unmet needs. The commercialization of its product, marketed in the United States for Niemann-Pick disease type C (NPC), a rare, progressive neurodegenerative disease, provides a corporate foundation and demonstrates its ability to advance therapies from development to market.

Share on Social Networks: